Mirum Pharmaceuticals, Inc.
MIRM- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001759425
In the last 90 days, Mirum Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 10 sales; 326 institutions reported holding it in 13F filings for Q2 2026, worth $8.36B in total; no superinvestor holds it.
13F holders, Q4 2023
Institutional positions in Mirum Pharmaceuticals, Inc. as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 187
- +29 vs. Q3 2023
- Shares held
- 50.3M
- +1.40M (+2.9%) vs. Q3 2023
- Total value
- $1.48B
- −$59.6M (−3.9%) vs. Q3 2023
- New holders
- 45
- 69 more added
- Sold out
- 16
- 52 more reduced
1 institution that held it in Q3 2023 haven't filed for Q4 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting MIRM on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 326 | $8.36B |
| Q1 2026 | 311 | $6.29B |
| Q4 2025 | 284 | $4.82B |
| Q3 2025 | 272 | $4.20B |
| Q2 2025 | 214 | $2.82B |
| Q1 2025 | 214 | $2.44B |
| Q4 2024 | 205 | $2.19B |
| Q3 2024 | 178 | $2.08B |
| Q2 2024 | 161 | $1.83B |
| Q1 2024 | 172 | $1.34B |
| Q4 2023 | 187 | $1.48B |
| Q3 2023 | 159 | $1.55B |
| Q2 2023 | 146 | $955.6M |
| Q1 2023 | 117 | $832.9M |
| Q4 2022 | 104 | $650.2M |
| Q3 2022 | 112 | $709.1M |
| Q2 2022 | 110 | $569.4M |
| Q1 2022 | 99 | $590.4M |
| Q4 2021 | 86 | $395.7M |
| Q3 2021 | 73 | $465.0M |
| Q2 2021 | 67 | $404.6M |
| Q1 2021 | 61 | $463.3M |
Institutions, Q4 2023
Shares, value and share of portfolio for each institution holding Mirum Pharmaceuticals, Inc.; share changes are against Q3 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Virtus Fund Advisers, LLC | 0 | $0 | 0.00% | −1,069−100.0% | Sold out |
| Oliver Lagore Vanvalin Investment Group | 0 | $0 | 0.00% | −162−100.0% | Sold out |
| Paladin Advisory Group, LLC | 0 | $0 | 0.00% | −131−100.0% | Sold out |
| International Biotechnology Trust PLC | – | – | – | – | Not filed |